Berlin Heals Holding AG Secures Funding for Revolutionary C-MIC Device
June 19, 2024, 4:20 am
Berlin Heals Holding AG has achieved a major milestone in the development of the C-MIC device, a groundbreaking treatment for heart failure. The company recently secured additional funding, bringing them closer to obtaining CE approval for this life-saving technology. With the potential to revolutionize the treatment of heart failure, the C-MIC device has shown remarkable clinical improvements in patients, offering hope for a better quality of life and extended life expectancy.
The C-MIC device, developed by Berlin Heals Holding AG, is a game changer in the field of heart failure treatment. Through the use of a constant electrical microcurrent, the device effectively improves inflammatory parameters in the heart tissue and flushes out excess water, providing patients with significant relief and improved cardiac performance.
With successful implantations in randomized studies and promising results from pilot studies, Berlin Heals Holding AG has garnered support from both new and existing investors, securing the necessary funding for CE approval. This financial backing not only paves the way for regulatory approval in Europe but also sets the stage for future studies and potential approval in the United States.
Patients who have received the C-MIC implant have reported a remarkable sense of well-being, with many still maintaining a high level of physical activity and quality of life. The success of the device has caught the attention of the FDA, further endorsing its potential as a game-changing treatment for heart failure.
Marko Bagaric, CEO of Berlin Heals Holding AG, expressed confidence in the C-MIC device, stating that it has the potential to set a new standard in the treatment of heart failure. With a simple and minimally invasive procedure, patients can experience significant improvements in their condition within a matter of weeks, offering hope for a brighter future.
Berlin Heals Holding AG, a Swiss corporation with a global presence, is at the forefront of innovation in cardiac care. The C-MIC device represents a significant advancement in the treatment of heart failure, offering patients a new lease on life and the promise of improved outcomes.
As Berlin Heals Holding AG continues to make strides towards regulatory approval and market availability, the future looks bright for patients suffering from heart failure. With the support of investors and regulatory agencies, the C-MIC device is poised to make a lasting impact on the field of cardiac care, offering hope and healing to those in need.
The C-MIC device, developed by Berlin Heals Holding AG, is a game changer in the field of heart failure treatment. Through the use of a constant electrical microcurrent, the device effectively improves inflammatory parameters in the heart tissue and flushes out excess water, providing patients with significant relief and improved cardiac performance.
With successful implantations in randomized studies and promising results from pilot studies, Berlin Heals Holding AG has garnered support from both new and existing investors, securing the necessary funding for CE approval. This financial backing not only paves the way for regulatory approval in Europe but also sets the stage for future studies and potential approval in the United States.
Patients who have received the C-MIC implant have reported a remarkable sense of well-being, with many still maintaining a high level of physical activity and quality of life. The success of the device has caught the attention of the FDA, further endorsing its potential as a game-changing treatment for heart failure.
Marko Bagaric, CEO of Berlin Heals Holding AG, expressed confidence in the C-MIC device, stating that it has the potential to set a new standard in the treatment of heart failure. With a simple and minimally invasive procedure, patients can experience significant improvements in their condition within a matter of weeks, offering hope for a brighter future.
Berlin Heals Holding AG, a Swiss corporation with a global presence, is at the forefront of innovation in cardiac care. The C-MIC device represents a significant advancement in the treatment of heart failure, offering patients a new lease on life and the promise of improved outcomes.
As Berlin Heals Holding AG continues to make strides towards regulatory approval and market availability, the future looks bright for patients suffering from heart failure. With the support of investors and regulatory agencies, the C-MIC device is poised to make a lasting impact on the field of cardiac care, offering hope and healing to those in need.